Skip to content

Mucus in paediatric mechanical ventilation.

The effect of nebulisation of ipratropiumbromide on end-expiratory lung volume and oxygenation in mechanically ventilated children: a pilot study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24021
Enrollment
45
Registered
2009-08-10
Start date
2009-01-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical ventilation, sputum productgion

Interventions

Patients will be randomized to either nebulisation of ipratropiumbromide (if age less than 4 years 125 micrograms, if age > 4 years then 250 micrograms) four times a day, endotracheal installation of

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children are eligible for inclusion if they meet the following criteria: 1. Pressure-controlled mechanical ventilation for at least 24 hours; 2. Endotracheal tube leakage < 5% (as measured by the mechanical ventilator); 3. Informed consent obtained from parents or legal caretakers.

Exclusion criteria

Exclusion criteria: 1. Mechanical ventilation less than 24 hours or children on high-frequency oscillatory ventilation; 2. Endotracheal tube leakage > 5%; 3. Pre-existing pulmonary abnormalities; 4. Pre-existing congenital heart disease with significant left-to-right shunt.

Design outcomes

Primary

MeasureTime frame
To study the differences in changes in EELV between mechanically ventilated children after endotracheal suctioning with prior nebulisation of ipratropriumbromide, prior instillation of NaCl 0.9% or nothing.

Secondary

MeasureTime frame
To study the differences in PaO2/FiO2 and oxygenation index between mechanically ventilated children after endotracheal suctioning with prior nebulisation of ipratropriumbromide, prior instillation of NaCl 0.9% or nothing.

Contacts

Public ContactM.C.J. Kneyber (UMCG)

Beatrix Children's Hospital/University Medical Center Groningen P.O. Box 30.001

m.c.j.kneyber@bkk.umcg.nl+31 (0)50-3614147

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)